Toggle navigation
TWunroll
TWunroll
faq
Contact US
brendan
brendan_49
$ANNX was founded on Ben Barres discovery that C1q prunes synapses in normal development and neurodegen. ANNX ultimate aim, I think, is Alzheimers, but more efficient paths first in Guillain-Barre
Read more
The rationale for ROR1 as CAR-T target:1) Expression restricted to fetus and tumors. If ADC's are safe CARs should be too.2) ADCs nabbed monotherapy CRs in MCL.3) Diverse tumors evolve
Read more
Some random facts about $FATE (engineered NK cells) that might be interesting to my $AFMD (mabs w/ affinity to preload NK cells) and $GMDA (proprietary NK cell expansion combined w/
Read more
10,000 foot view on $CNCE and schizo. Cartoon lingo so all can follow. One feature of schizo is too much dopamine. Dopamine blockers reduce psychosis and hallucinations. But schizos remain
Read more
$AFMD is up 70% vs. one year ago vs. 50% for $XBI. Modest outperformance. Here's what's changed in the last year:1) AFM13 registrational trial in CD30+ PTCL trial WAS initiating,
Read more
Basic view/strat on various stocks:$OCUL - big weight, riding indefinitely.$REPL - ditto. I believe in vision of OV's as backbone PD1 combo.$FGEN - bullish on US regulatory outcome, bullish on
Read more
By continuing to use the site, you are consenting to the use of cookies as explained in our
Cookie Policy
to improve your experience.
I agree